Bonviva

Bonviva Indications/Uses

ibandronic acid

Manufacturer:

Atnahs

Distributor:

DKSH
Full Prescribing Info
Indications/Uses
Treatment of postmenopausal osteoporosis: Bonviva 150 mg is indicated for the treatment of postmenopausal osteoporosis, to reduce the risk of fractures.
Osteoporosis may be confirmed by the finding of low bone mass (T-score <-2.0 SD) and the presence or history of osteoporotic fracture, or a low bone mass (T-score < -2.5 SD) in the absence of documented pre-existing osteoporotic fracture.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in